![](/img/cover-not-exists.png)
The US Food and Drug Administration’s expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation
Wallach, Joshua D, Ross, Joseph S, Naci, HuseyinVolume:
15
Language:
english
Journal:
Clinical Trials
DOI:
10.1177/1740774518770657
Date:
June, 2018
File:
PDF, 83 KB
english, 2018